ProQR Therapeutics NV
NASDAQ:PRQR
Income Statement
Earnings Waterfall
ProQR Therapeutics NV
Revenue
|
9.5m
EUR
|
Operating Expenses
|
-41.4m
EUR
|
Operating Income
|
-31.9m
EUR
|
Other Expenses
|
3.7m
EUR
|
Net Income
|
-28.1m
EUR
|
Income Statement
ProQR Therapeutics NV
Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
1
+110%
|
1
+115%
|
3
+85%
|
3
+25%
|
4
+11%
|
3
-4%
|
3
-22%
|
2
-32%
|
2
-16%
|
1
-21%
|
1
-10%
|
2
+38%
|
2
+7%
|
2
+43%
|
5
+114%
|
6
+17%
|
6
-1%
|
5
-7%
|
3
-46%
|
2
-32%
|
2
-8%
|
10
+458%
|
10
-3%
|
9
-2%
|
9
-1%
|
1
-86%
|
2
+70%
|
2
+9%
|
3
+45%
|
4
+11%
|
4
-7%
|
5
+34%
|
4
-18%
|
4
+5%
|
5
+12%
|
10
+106%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(17)
|
(22)
|
(24)
|
(27)
|
(30)
|
(33)
|
(37)
|
(40)
|
(41)
|
(42)
|
(41)
|
(41)
|
(42)
|
(42)
|
(40)
|
(39)
|
(42)
|
(47)
|
(51)
|
(56)
|
(59)
|
(61)
|
(61)
|
(58)
|
(52)
|
(47)
|
(49)
|
(54)
|
(60)
|
(66)
|
(69)
|
(74)
|
(70)
|
(61)
|
(55)
|
(43)
|
(41)
|
|
Selling, General & Administrative |
(7)
|
(8)
|
(8)
|
(7)
|
(7)
|
(8)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(11)
|
(11)
|
(11)
|
(11)
|
(12)
|
(13)
|
(13)
|
(14)
|
(12)
|
(14)
|
(14)
|
(14)
|
(13)
|
(13)
|
(14)
|
(16)
|
(17)
|
(19)
|
(20)
|
(21)
|
(18)
|
(18)
|
(17)
|
(14)
|
(16)
|
|
Research & Development |
(10)
|
(14)
|
(17)
|
(20)
|
(23)
|
(25)
|
(28)
|
(30)
|
(31)
|
(33)
|
(32)
|
(31)
|
(30)
|
(31)
|
(29)
|
(28)
|
(29)
|
(34)
|
(37)
|
(42)
|
(45)
|
(47)
|
(46)
|
(44)
|
(36)
|
(34)
|
(35)
|
(38)
|
(41)
|
(47)
|
(48)
|
(53)
|
(49)
|
(44)
|
(38)
|
(28)
|
(23)
|
|
Depreciation & Amortization |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(3)
|
|
Operating Income |
(16)
N/A
|
(21)
-30%
|
(23)
-8%
|
(24)
-6%
|
(27)
-10%
|
(29)
-8%
|
(33)
-14%
|
(37)
-11%
|
(40)
-7%
|
(41)
-3%
|
(40)
+1%
|
(40)
+1%
|
(41)
-1%
|
(40)
+0%
|
(38)
+6%
|
(34)
+10%
|
(36)
-6%
|
(41)
-13%
|
(45)
-10%
|
(53)
-17%
|
(57)
-9%
|
(59)
-3%
|
(51)
+14%
|
(48)
+5%
|
(42)
+12%
|
(38)
+10%
|
(48)
-26%
|
(52)
-8%
|
(57)
-11%
|
(62)
-9%
|
(65)
-4%
|
(70)
-8%
|
(65)
+8%
|
(57)
+11%
|
(50)
+12%
|
(38)
+25%
|
(32)
+16%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
4
|
11
|
9
|
8
|
6
|
(2)
|
1
|
0
|
0
|
1
|
(1)
|
(1)
|
(3)
|
(4)
|
(2)
|
(1)
|
(1)
|
1
|
0
|
2
|
1
|
1
|
(0)
|
(4)
|
(4)
|
(5)
|
(7)
|
(5)
|
(4)
|
(1)
|
3
|
4
|
1
|
1
|
1
|
1
|
2
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
(3)
|
(1)
|
(1)
|
(2)
|
3
|
2
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(12)
N/A
|
(10)
+18%
|
(14)
-38%
|
(17)
-21%
|
(21)
-24%
|
(31)
-50%
|
(33)
-4%
|
(36)
-12%
|
(39)
-7%
|
(39)
-1%
|
(41)
-4%
|
(41)
-1%
|
(44)
-6%
|
(44)
-1%
|
(40)
+9%
|
(35)
+11%
|
(37)
-5%
|
(41)
-9%
|
(45)
-11%
|
(51)
-14%
|
(57)
-11%
|
(58)
-3%
|
(51)
+13%
|
(52)
-2%
|
(46)
+10%
|
(43)
+7%
|
(55)
-27%
|
(57)
-4%
|
(62)
-9%
|
(63)
-2%
|
(61)
+4%
|
(69)
-13%
|
(65)
+6%
|
(57)
+12%
|
(52)
+10%
|
(34)
+35%
|
(28)
+18%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
Income from Continuing Operations |
(12)
|
(10)
|
(14)
|
(17)
|
(21)
|
(31)
|
(33)
|
(36)
|
(39)
|
(39)
|
(41)
|
(41)
|
(44)
|
(44)
|
(40)
|
(35)
|
(37)
|
(41)
|
(45)
|
(51)
|
(57)
|
(59)
|
(51)
|
(52)
|
(47)
|
(43)
|
(55)
|
(57)
|
(62)
|
(63)
|
(61)
|
(69)
|
(65)
|
(57)
|
(52)
|
(34)
|
(28)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Net Income (Common) |
(12)
N/A
|
(10)
+18%
|
(14)
-38%
|
(17)
-21%
|
(21)
-24%
|
(31)
-50%
|
(33)
-4%
|
(36)
-12%
|
(39)
-7%
|
(39)
-1%
|
(41)
-4%
|
(41)
-1%
|
(44)
-6%
|
(44)
0%
|
(40)
+9%
|
(35)
+11%
|
(37)
-5%
|
(40)
-9%
|
(45)
-11%
|
(51)
-14%
|
(56)
-11%
|
(58)
-3%
|
(51)
+13%
|
(52)
-2%
|
(47)
+10%
|
(43)
+7%
|
(55)
-27%
|
(57)
-3%
|
(62)
-9%
|
(63)
-2%
|
(61)
+3%
|
(69)
-14%
|
(65)
+6%
|
(57)
+12%
|
(52)
+10%
|
(34)
+34%
|
(28)
+17%
|
|
EPS (Diluted) |
-0.52
N/A
|
-0.4
+23%
|
-0.59
-48%
|
-0.72
-22%
|
-0.89
-24%
|
-1.34
-51%
|
-1.4
-4%
|
-1.56
-11%
|
-1.67
-7%
|
-1.69
-1%
|
-1.7
-1%
|
-1.62
+5%
|
-1.72
-6%
|
-1.37
+20%
|
-1.24
+9%
|
-1.05
+15%
|
-1.08
-3%
|
-1.03
+5%
|
-1.14
-11%
|
-1.3
-14%
|
-1.38
-6%
|
-1.16
+16%
|
-1.01
+13%
|
-1.05
-4%
|
-0.93
+11%
|
-0.85
+9%
|
-0.82
+4%
|
-0.82
N/A
|
-0.96
-17%
|
-0.88
+8%
|
-0.87
+1%
|
-0.98
-13%
|
-0.91
+7%
|
-0.7
+23%
|
-0.63
+10%
|
-0.41
+35%
|
-0.35
+15%
|